title: Alteplase as hemodialysis catheter locking solution and spurious hyperphosphatemia.
authors.forename: Kostas
authors.initials: K
authors.lastname: Sombolos
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Bamichas
authors.forename: Victoria
authors.initials: V
authors.lastname: Hatsiou
authors.forename: Stelios
authors.initials: S
authors.lastname: Fragidis
authors.forename: Athanasios
authors.initials: A
authors.lastname: Rizos
authors.forename: Taisir
authors.initials: T
authors.lastname: Natse
authors.forename: Christina
authors.initials: C
authors.lastname: Fytili
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002675:Child, Preschool; D003951:Diagnostic Errors / Q000517:prevention & control; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006115:Greece; D006801:Humans; D054559:Hyperphosphatemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood; D011237:Predictive Value of Tests; D006435:Renal Dialysis; D015203:Reproducibility of Results; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*; D056824:Upper Extremity Deep Vein Thrombosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D015415:Biomarkers; D005343:Fibrinolytic Agents; D010758:Phosphorus; D010959:Tissue Plasminogen Activator